NCT03219060 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Duaso MJ, Bakhshi S, Mujika A, Purssell E, While AE
Nurses' smoking habits and their professional smoking cessation practices. A systematic review and meta-analysis. Int J Nurs Stud. 2017 Feb;67:3-11. doi: 10.1016/j.ijnurstu.2016.10.011. Epub 2016 Nov 2. Review.
Duaso MJ, McDermott MS, Mujika A, Purssell E, While A
Do doctors' smoking habits influence their smoking cessation practices? A systematic review and meta-analysis. Addiction. 2014 Nov;109(11):1811-23. doi: 10.1111/add.12680. Epub 2014 Aug 5. Review.
Mujika A, Arantzamendi M, Lopez-Dicastillo O, Forbes A
Health professionals' personal behaviours hindering health promotion: A study of nurses who smoke. J Adv Nurs. 2017 May 24. doi: 10.1111/jan.13343. [Epub ahead of print]
Mujika A, Forbes A, Canga N, de Irala J, Serrano I, Gascó P, Edwards M
Motivational interviewing as a smoking cessation strategy with nurses: an exploratory randomised controlled trial. Int J Nurs Stud. 2014 Aug;51(8):1074-82. doi: 10.1016/j.ijnurstu.201

Motivational Interviewing as a Smoking Cessation Strategy With Nurses: an Exploratory Randomized Controlled Trial Following the MRC's Framework for Complex Interventions

Details for clinical trial NCT03219060

Clinical trial NCT03219060 - References